Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis

被引:296
作者
Kim, N [1 ]
Kadono, Y
Takami, M
Lee, J
Lee, SH
Okada, F
Kim, JH
Kobayashi, T
Odgren, PR
Nakano, H
Yeh, WC
Lee, SK
Lorenzo, JA
Choi, Y
机构
[1] Chonnam Natl Univ, Sch Med, Med Res Ctr Gene Regulat, Kwangju 501746, South Korea
[2] Univ Penn, Sch Med, Dept Pathol & Lab Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA
[3] Showa Univ, Sch Dent, Dept Biochem, Shinagawa Ku, Tokyo 1428555, Japan
[4] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA
[5] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1138421, Japan
[6] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada
[7] Univ Connecticut, Dept Med, Div Endocrinol, Ctr Hlth, Farmington, CT 06030 USA
关键词
D O I
10.1084/jem.20050978
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Osteoclasts are derived from myeloid lineage cells, and their differentiation is supported by various osteotropic factors, including the tumor necrosis factor (TNF) family member TNF-related activation-induced cytokine (TRANCE). Genetic deletion of TRANCE or its receptor, receptor activator of nuclear factor kappa B (RANK), results in severely osteopetrotic mice with no osteoclasts in their bones. TNF receptor-associated factor (TRAF) 6 is a key signaling adaptor for RANK, and its deficiency leads to similar osteopetrosis. Hence, the current paradigm holds that TRANCE-RANK interaction and subsequent signaling via TRAF6 are essential for the generation of functional osteoclasts. Surprisingly, we show that hematopoietic precursors from TRANCE-, RANK-, or TRAF6-null mice can become osteoclasts in vitro when they are stimulated with TNF-alpha in the presence of cofactors such as TGF-beta. We provide direct evidence against the current paradigm that the TRANCE-RANK-TRAF6 pathway is essential for osteoclast differentiation and suggest the potential existence of alternative routes for osteoclast differentiation.
引用
收藏
页码:589 / 595
页数:7
相关论文
共 24 条
[1]   A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function [J].
Armstrong, AP ;
Tometsko, ME ;
Glaccum, M ;
Sutherland, CL ;
Cosman, D ;
Dougall, WC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (46) :44347-44356
[2]   Tumor necrosis factor-α induces differentiation of and bone resorption by osteoclasts [J].
Azuma, Y ;
Kaji, K ;
Katogi, R ;
Takeshita, S ;
Kudo, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (07) :4858-4864
[3]   Osteoclast differentiation and activation [J].
Boyle, WJ ;
Simonet, WS ;
Lacey, DL .
NATURE, 2003, 423 (6937) :337-342
[4]   TARF6 is a signal transducer for interleukin-1 [J].
Cao, ZD ;
Xiong, J ;
Takeuchi, M ;
Kurama, T ;
Goeddel, DV .
NATURE, 1996, 383 (6599) :443-446
[5]   RANK is essential for osteoclast and lymph node development [J].
Dougall, WC ;
Glaccum, M ;
Charrier, K ;
Rohrbach, K ;
Brasel, K ;
De Smedt, T ;
Daro, E ;
Smith, J ;
Tometsko, ME ;
Maliszewski, CR ;
Armstrong, A ;
Shen, V ;
Bain, S ;
Cosman, D ;
Anderson, D ;
Morrissey, PJ ;
Peschon, JJ ;
Schuh, J .
GENES & DEVELOPMENT, 1999, 13 (18) :2412-2424
[6]  
Fuller K, 2000, J CELL SCI, V113, P2445
[7]   TNFa potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL [J].
Fuller, K ;
Murphy, C ;
Kirstein, B ;
Fox, SW ;
Chambers, TJ .
ENDOCRINOLOGY, 2002, 143 (03) :1108-1118
[8]   TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts [J].
Fuller, K ;
Wong, B ;
Fox, S ;
Choi, YW ;
Chambers, TJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (05) :997-1001
[9]   Strength of TRAF6 signalling determines osteoclastogenesis [J].
Kadono, Y ;
Okada, F ;
Perchonock, C ;
Jang, HD ;
Lee, SY ;
Kim, N ;
Choi, Y .
EMBO REPORTS, 2005, 6 (02) :171-176
[10]   TRAF5 functions in both RANKL- and TNFα-induced osteoclastogenesis [J].
Kanazawa, K ;
Azuma, Y ;
Nakano, H ;
Kudo, A .
JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (03) :443-450